Mark Neumann

Mr. Neumann joined the Company as Executive Vice President and Chief Commercial Officer in October 2018. Mr. Neumann has over 30 years of biopharmaceutical industry experience with a strong track record of building high-performing commercial teams and successfully executing numerous product launches across a range of therapeutic areas. Mark joins ITCI from Amgen where he was initially recruited as Vice President, Marketing to build and establish a new U.S. cardiovascular business unit, and launch Amgen’s first ever cardiovascular medicines. In his most recent role as Vice President, Global Marketing with leadership of nephrology, inflammation, and bone health, Mr. Neumann was responsible for conceiving therapeutic area strategies, developing marketing platforms for global launches and directing commercial assessments for external business development opportunities.